Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Employer
-
Field
-
29th March 2026 Languages English English English The Department of Chemical Engineering has a vacancy for a PhD Candidate in Process Systems Engineering and Real-Time Optimization Apply
-
that maintain stable operation under variability, recover quickly from disturbances, and remain reliable in remote, harsh, or unpredictable conditions. This demands optimized system sizing, robust control
-
-support layer, integrating multi-modal data, domain knowledge, and diverse requirements into optimized, explainable maintenance strategies that maximize power supply resilience and control cost. Duties
-
globally, causing substantial disability and healthcare burden. Anti-CGRP monoclonal antibodies (mABs) have transformed migraine prevention, but questions remain about optimal treatment duration and outcomes
-
(SKO1109) is open in the Experimental Cancer Immunotherapy Group led by Johanna Olweus, MD, PhD, at Deptartment of Cancer Immunology, Institute for Cancer Research, Division of Cancer Medicine, Institute
-
), Guidelines concerning appointment to post doctoral and research posts at UiO (Norwegian) and Regulations for the degree of Philosophiae Doctor (PhD) at the University of Oslo . The University of Oslo has a
-
universities and colleges chapter 3 (Norwegian), Guidelines concerning appointment to post doctoral and research posts at UiO (Norwegian) and Regulations for the degree of Philosophiae Doctor (PhD
-
colleges chapter 3 (Norwegian), Guidelines concerning appointment to post doctoral and research posts at UiO (Norwegian) and Regulations for the degree of Philosophiae Doctor (PhD) at the University
-
professors, post-docs, researchers, technical, and administrative personnel, the Department has a total staff of 260 from more than 30 different countries. The Department aims to maintain high international
-
Immunotherapy Apply for this job See advertisement About the position / About the job A position as Researcher (SKO1109) is open in the Experimental Cancer Immunotherapy Group led by Johanna Olweus, MD, PhD